Cargando…
Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
Despite the remarkable success of chimeric antigen receptor (CAR)-T cells against hematologic malignancies, severe off-tumor effects have constrained their use against solid tumors. Recently, CAR-engineered natural killer (NK) cells have emerged as an effective and safe alternative. Here, we demonst...
Autores principales: | Portillo, Ana L., Hogg, Richard, Poznanski, Sophie M., Rojas, Eduardo A., Cashell, Niamh J., Hammill, Joanne A., Chew, Marianne V., Shenouda, Mira M., Ritchie, Tyrah M., Cao, Quynh T., Hirota, Jeremy A., Dhesy-Thind, Sukhbinder, Bramson, Jonathan L., Ashkar, Ali A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193615/ https://www.ncbi.nlm.nih.gov/pubmed/34159300 http://dx.doi.org/10.1016/j.isci.2021.102619 |
Ejemplares similares
-
Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment
por: Portillo, Ana L., et al.
Publicado: (2023) -
Expanded human NK cells from lung cancer patients sensitize patients’ PDL1−negative tumors to PD1-blockade therapy
por: Poznanski, Sophie M, et al.
Publicado: (2021) -
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
por: Shenouda, Mira M., et al.
Publicado: (2017) -
Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells
por: Vahedi, Fatemeh, et al.
Publicado: (2017) -
What Defines NK Cell Functional Fate: Phenotype or Metabolism?
por: Poznanski, Sophie M., et al.
Publicado: (2019)